V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270016547 | 270009367 | 1.75 | 98.8 | Curative (C) | 2013-10-14 | 2018-05-19 | Capecitabine (14 day) + Irinotecan | N | N | 270015655 | CAPECITABINE + IRINOTECAN |
| 270016548 | 270009371 | 0 | 52.6 | Neo-adjuvant (N) | 2015-06-22 | 2015-06-28 | CISPLATIN + FLUOROURACIL | 02 | Y | 270015661 | CISPLATIN + FLUOROURACIL |
| 270016549 | 270009372 | null | 86.8 | Palliative (P) | 2017-02-03 | 2017-02-12 | Trifluridine + Tipiracil | 99 | null | 270015665 | TRIFLURIDINE + TIPIRACIL |
| 270016550 | 270014381 | null | null | Palliative (P) | 2014-06-13 | 2015-10-10 | CISPLATIN + FLUOROURACIL | N | N | 270015678 | CISPLATIN + FLUOROURACIL |
| 270016551 | 270014382 | 1.75 | 90.2 | Curative (C) | null | 2016-08-24 | DHAP | N | N | 270015679 | DHAP |
| 270016552 | 270009378 | null | null | Curative (C) | null | 2018-09-06 | DHAP | null | Y | 270015692 | DHAP |
| 270016553 | 270009380 | 1.76 | 118.2 | Palliative (P) | 2015-12-30 | 2016-01-20 | Trifluridine + Tipiracil | N | null | 270015700 | TRIFLURIDINE + TIPIRACIL |
| 270016554 | 270014385 | 1.77 | 51.3 | Palliative (P) | 2015-09-16 | 2015-09-30 | Shamash LBCMVD-56 | N | N | 270015702 | NOT MATCHED |
| 270016555 | 270014385 | 1.57 | 48.6 | Curative (C) | 2012-03-03 | 2015-10-02 | DHAP | null | null | 270015702 | DHAP |
| 270016556 | 270009382 | null | 78.5 | Curative (C) | 2015-02-27 | 2015-07-18 | BLEOMYCIN + CYCLOPHOSPHAMIDE + ETOPOSIDE + GEMCITABINE + VINCRISTINE | N | N | 270015706 | NOT MATCHED |
| 270016557 | 270014386 | 1.8 | 86.1 | Curative (C) | 2016-08-17 | 2016-11-11 | CAPECITABINE + RT | 02 | N | 270015714 | CAPECITABINE + RT |
| 270016558 | 270009383 | 1.55 | 91.7 | Curative (C) | null | 2017-05-02 | DHAP | N | N | 270015716 | DHAP |
| 270016559 | 270016912 | 1.78 | 75 | Not known (9) | 2015-01-17 | 2015-02-10 | Fluorouricil + Folonic Acid (MdG) | N | N | 270015717 | FLUOROURACIL |
| 270016560 | 270009386 | 1.76 | 52.6 | Curative (C) | 2017-12-17 | 2017-12-30 | CHOP R - 21 days | N | Y | 270015721 | CHOP R |
| 270016561 | 270009387 | null | 63.85 | Adjuvant (A) | 2014-09-27 | 2015-02-06 | Trifluridine + Tipiracil | N | null | 270015734 | TRIFLURIDINE + TIPIRACIL |
| 270016562 | 270009389 | 1.61 | 72.8 | Curative (C) | 2014-10-23 | 2014-10-26 | CISPLATIN + FLUOROURACIL | N | N | 270015743 | CISPLATIN + FLUOROURACIL |
| 270016563 | 270009390 | 1.73 | 75 | Palliative (P) | null | 2015-08-14 | Trifluridine + Tipiracil | null | null | 270015762 | TRIFLURIDINE + TIPIRACIL |
| 270016564 | 270016916 | 1.58 | 87.1 | Not known (9) | 2015-12-26 | 2016-01-31 | Fluouracil continuous infusion | N | null | 270015765 | FLUOROURACIL |
| 270016565 | 270014394 | 1.82 | 71.6 | Curative (C) | 2014-07-27 | 2014-07-29 | CHOP R | N | Y | 270015768 | CHOP R |
| 270016566 | 270009393 | 1.57 | 52.4 | Curative (C) | 2018-08-20 | 2019-05-22 | Cetuximab + Radiotherapy Maint | N | N | 270015769 | CETUXIMAB + RT |
| 270016567 | 270009395 | null | null | Palliative (P) | 2016-02-04 | 2016-02-04 | CHLVPP | 2 | Y | 270015772 | CHLVPP |
| 270016568 | 270009396 | null | 88.2 | Palliative (P) | 2017-11-07 | 2017-11-16 | CHLVPP | N | N | 270015773 | CHLVPP |
| 270016569 | 270009396 | 1.68 | 78.2 | Palliative (P) | 2016-11-04 | 2016-11-18 | CHLVPP | 2 | null | 270015773 | CHLVPP |
| 270016570 | 270009397 | 1.59 | 74.3 | Adjuvant (A) | 2019-02-13 | 2019-03-06 | Fluorouricil + Folonic Acid (MdG) | 02 | N | 270015775 | FLUOROURACIL |
| 270016571 | 270009400 | null | null | Curative (C) | 2017-08-21 | 2017-08-24 | Cetuximab + Radiotherapy Load | null | null | 270015784 | CETUXIMAB + RT |
| 270016572 | 270009400 | 1.7 | 80 | Not known (9) | null | 2014-02-03 | Fluorouricil + Folonic Acid (MdG) | N | N | 270015784 | FLUOROURACIL |
| 270016573 | 270020079 | 1.62 | 49.9 | Curative (C) | 2015-08-05 | 2015-08-15 | CAPECITABINE + RT | N | Y | 270015795 | CAPECITABINE + RT |
| 270016574 | 270009409 | 1.72 | 62.2 | Palliative (P) | 2017-07-30 | 2017-07-30 | Capecitabine 35days + RT | N | N | 270015818 | CAPECITABINE + RT |
| 270016575 | 270014399 | 1.9 | 83.4 | Curative (C) | 2017-06-16 | 2017-09-07 | HD Lymph Pred EuroNet-PHL-LP1 CVP | 02 | Y | 270015819 | NOT MATCHED |
| 270016576 | 270009417 | 1.84 | 87 | Palliative (P) | 2015-03-18 | 2015-03-18 | Bevacizumab + Oxaliplatin +MdG | 02 | N | 270015843 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270016577 | 270009421 | 1.46 | 97 | Not known (9) | 2013-12-06 | 2013-12-07 | Fluorouricil + Folonic Acid (MdG) | N | N | 270015853 | FLUOROURACIL |
| 270016578 | 270009422 | 1.43 | 62.9 | Curative (C) | 2015-08-26 | 2015-09-02 | DHAP | N | N | 270015859 | DHAP |
| 270016579 | 270014405 | 1.9 | 57.2 | Not known (9) | 2013-05-29 | 2017-12-27 | Fluorouricil + Folonic Acid (MdG) | 02 | N | 270015860 | FLUOROURACIL |
| 270016580 | 270014405 | null | null | Palliative (P) | 2016-07-13 | 2016-08-07 | Bevacizumab + Oxaliplatin +MdG | 02 | Y | 270015860 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270016581 | 270009425 | 1.69 | 89.05 | Palliative (P) | 2014-11-11 | 2014-11-11 | CISPLATIN + FLUOROURACIL | 2 | N | 270015867 | CISPLATIN + FLUOROURACIL |
| 270016582 | 270009428 | null | null | Curative (C) | 2017-10-26 | 2018-02-20 | Capecitabine 35days + RT | N | Y | 270015870 | CAPECITABINE + RT |
| 270016583 | 270009429 | 1.6 | 75 | Neo-adjuvant (N) | 2018-01-05 | 2018-01-12 | Cetuximab + Radiotherapy Maint | 2 | null | 270015870 | CETUXIMAB + RT |
| 270016584 | 270009431 | 1.71 | 67.5 | Palliative (P) | 2017-05-18 | 2017-05-18 | CHOP R | 02 | null | 270015884 | CHOP R |
| 270016585 | 270019936 | 1.72 | 78.2 | Curative (C) | 2015-09-01 | 2015-09-01 | CHOP R - 21 days | 02 | N | 270015886 | CHOP R |
| 270016586 | 270014411 | 1.7 | 80.75 | Neo-adjuvant (N) | 2015-07-07 | 2015-07-15 | Capecitabine 35days + RT | N | N | 270015887 | CAPECITABINE + RT |
| 270016587 | 270016929 | 1.78 | 56.95 | Palliative (P) | null | 2016-05-31 | null | N | N | 270015888 | NOT MATCHED |
| 270016588 | 270009435 | 1.63 | 70 | Disease modification (D) | 2014-06-06 | 2014-06-06 | CHLVPP | N | N | 270015891 | CHLVPP |
| 270016589 | 270014413 | 1.6 | 66.9 | Neo-adjuvant (N) | 2009-03-27 | 2013-05-28 | Cetuximab + Radiotherapy Maint | 2 | N | 270015893 | CETUXIMAB + RT |
| 270016590 | 270009440 | 1.84 | 74 | null | 2014-11-06 | 2014-12-05 | Bevacizumab + Oxaliplatin +MdG | N | null | 270015908 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270016591 | 270009442 | 1.79 | 48.4 | Disease modification (D) | 2016-05-02 | 2016-05-07 | CHOP R | 02 | N | 270015909 | CHOP R |
| 270016592 | 270009443 | 1.8 | 92 | Adjuvant (A) | 2014-02-28 | 2014-03-09 | CAPECITABINE + IRINOTECAN | N | N | 270015910 | CAPECITABINE + IRINOTECAN |
| 270016593 | 270019937 | 1.6 | 89 | Curative (C) | 2017-01-19 | 2017-12-26 | DHAP | N | N | 270015923 | DHAP |
| 270016594 | 270009447 | 1.88 | 75.6 | Palliative (P) | 2017-03-28 | 2017-04-04 | Cetuximab + Radiotherapy Maint | N | N | 270015929 | CETUXIMAB + RT |
| 270016595 | 270009449 | 1.75 | 96.2 | Palliative (P) | 2018-04-27 | 2018-05-01 | Capecitabine 35days + RT | 2 | N | 270015930 | CAPECITABINE + RT |
| 270016596 | 270009452 | 1.84 | 84.2 | Palliative (P) | 2015-04-23 | 2015-04-23 | Trifluridine + Tipiracil | 02 | N | 270015942 | TRIFLURIDINE + TIPIRACIL |